Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Open accessThe DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
The current approach of morbidity control of schistosomiasis, a helminth disease of poverty with considerable public health and socioeconomic impact, is based on preventive chemotherapy with praziquantel. There is a pressing need for new drugs against this disease whose control entirely depends on this single drug that has been widely used over the past 40 years. We argue that a broader anthelminthic approach supplementing praziquantel with new antischistosomals targeting different parasite development stages would not only increase efficacy but also reduce the risk for drug resistance. Repositioning drugs already approved for other diseases provides a shortcut to clinical trials, as it is expected that such drugs rapidly pass the regulatory authorities. The antischistosomal properties of antimalarial drugs (e.g., semisynthetic artemisinins, synthetic trioxolanes, trioxaquines and mefloquine) and of drugs being developed or registered for other purposes (e.g., moxidectin and miltefosin), administered alone or in combination with praziquantel, have been tested in the laboratory and clinical trials. Another avenue to follow is the continued search for new antischistosomal properties in plants. Here, we summarise recent progress made in schistosomiasis chemotherapy, placing particular emphasis on repositioning of existing drugs against schistosomiasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61949-2 · Cited by 2,444
Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., Casey, D. C., Charlson, F. J., Coates, M. M., Coggeshall, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31460-x · Cited by 2,163
Hotez, P. J., Alvarado, M., Basáñez, M.-G., Bolliger, I., Bourne, R., Boussinesq, M., Brooker, S. J., Brown, A. S., Buckle, G., Budke, C. M., et al. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002865 · Cited by 1,082
Self-citationThe genome of the blood fluke Schistosoma mansoni
Berriman, M., Haas, B. J., LoVerde, P. T., Wilson, R. A., Dillon, G. P., Cerqueira, G. C., Mashiyama, S. T., Al-Lazikani, B., Andrade, L. F., Ashton, P. D., et al. (2009) · Nature · doi:10.1038/nature08160 · Cited by 1,058
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954 · cited 1×
“Briefly, leaf extracts from the plant Artemisia annua recommended in Chinese traditional medicine against malaria (and other ailments), constituted the starting point for the development of the artemisinin-based combination therapy (ACT) currently in use against this infection [92, 93].”
BackgroundQuantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa
van der Werf, M. J., de Vlas, S. J., Brooker, S., Looman, C. W. N., Nagelkerke, N. J. D., Habbema, J. D. F., & Engels, D. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00029-9 · Cited by 951 · cited 2×
“(caused by any of the five other species) results in blood in the stool and diarrhoea with the liver and spleen affected in the longer term [2, 15].”
BackgroundHybrid Molecules with a Dual Mode of Action: Dream or Reality?
Meunier, B. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000843 · Cited by 929
King, C. H., Dickman, K., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 899 · cited 1×
“org/publicdomain/ze also mild symptoms, such as anaemia, diarrhoea, dysuria and exercise intolerance [6, 7], which were not previously counted by the Global Burden of Disease (GBD) study, schistosomiasis now comes second on the list of 18 (after the intestinal nematodes that are counted together) NTDs put forth by the…”
BackgroundPraziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Doenhoff, M. J., Cioli, D., & Utzinger, J. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328318978f · Cited by 806 · cited 1×
“Praziquantel, a highly efficacious pyrazinoisoquinoline derivative with a good safety profile and a broad spectrum against helminth infections, remains the drug of choice for schistosomiasis chemotherapy since almost 40 years [18, 19].”
BackgroundSelf-citationTime to set the agenda for schistosomiasis elimination
Rollinson, D., Knopp, S., Levitz, S., Stothard, J. R., Tchuem Tchuenté, L.-A., Garba, A., Mohammed, K. A., Schur, N., Person, B., Colley, D. G., et al. (2013) · Acta Tropica · doi:10.1016/j.actatropica.2012.04.013 · Cited by 617
Self-citationMolyneux, D. H., Hotez, P. J., & Fenwick, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020336 · Cited by 557 · cited 1×
“The disease is one of today’s foremost neglected tropical diseases (NTDs) and a disease of poverty [3, 4].”
BackgroundThe unacknowledged impact of chronic schistosomiasis
King, C. H., & Dangerfield-Cha, M. (2008) · Chronic Illness · doi:10.1177/1742395307084407 · Cited by 530 · cited 1×
“org/publicdomain/ze also mild symptoms, such as anaemia, diarrhoea, dysuria and exercise intolerance [6, 7], which were not previously counted by the Global Burden of Disease (GBD) study, schistosomiasis now comes second on the list of 18 (after the intestinal nematodes that are counted together) NTDs put forth by the…”
BackgroundMelman, S. D., Steinauer, M. L., Cunningham, C., Kubatko, L. S., Mwangi, I. N., Wynn, N. B., Mutuku, M. W., Karanja, D. M. S., Colley, D. G., Black, C. L., et al. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000504 · Cited by 445
Whole-genome sequence of Schistosoma haematobium
Young, N. D., Jex, A. R., Li, B., Liu, S., Yang, L., Xiong, Z., Li, Y., Cantacessi, C., Hall, R. S., Xu, X., et al. (2012) · Nature Genetics · doi:10.1038/ng.1065 · Cited by 423
Praziquantel, a new broad-spectrum antischistosomal agent
G�nnert, R., & Andrews, P. (1977) · Zeitschrift f�r Parasitenkunde · doi:10.1007/bf00389899 · Cited by 412 · cited 1×
“Praziquantel, a highly efficacious pyrazinoisoquinoline derivative with a good safety profile and a broad spectrum against helminth infections, remains the drug of choice for schistosomiasis chemotherapy since almost 40 years [18, 19].”
BackgroundMedicinal Plants: A Source of Anti-Parasitic Secondary Metabolites
Wink, M. (2012) · Molecules · doi:10.3390/molecules171112771 · Cited by 394
Drug Resistance in Human Helminths: Current Situation and Lessons from Livestock
Geerts, S., & Gryseels, B. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.207 · Cited by 355 · cited 1×
“Judging from the veterinary field, development of drug resistance in helminthiasis can be swift [35] and the situation with respect to malaria is a constant reminder of this risk [36].”
BackgroundThe drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment
Pedrique, B., Strub-Wourgaft, N., Some, C., Olliaro, P., Trouiller, P., Ford, N., Pécoul, B., & Bradol, J.-H. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70078-0 · Cited by 352 · cited 1×
“It is even more worrisome that the drug discovery and development pipeline for NTDs has run dry over the past 40 years [34].”
BackgroundSchistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control
Utzinger, J., & Keiser, J. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.2.263 · Cited by 329 · cited 1×
“mansoni [24, 25], and metrifonate, an insecticide based on inhibition of acetyl-cholinesterase that is efficacious against S.”
BackgroundSelf-citationIsmail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L.-F., & Bennett, J. L. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.214 · Cited by 315
Antiparasitic properties of medicinal plants and other naturally occurring products
TAGBOTO, S., & TOWNSON, S. (2001) · Advances in Parasitology · doi:10.1016/s0065-308x(01)50032-9 · Cited by 308
Drugs for the control of parasitic diseases: current status and development in schistosomiasis
Fenwick, A., Savioli, L., Engels, D., Robert Bergquist, N., & Todd, M. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.005 · Cited by 299 · cited 1×
“It has been used in preventive chemotherapy programmes in many endemic countries, in some continuously since more than 15 years [25, 110, 111].”
MethodGrimes, J. E. T., Croll, D., Harrison, W. E., Utzinger, J., Freeman, M. C., & Templeton, M. R. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003296 · Cited by 296 · cited 1×
“However, control – let alone elimination – of schistosomiasis has proven difficult because of rapid re-infection due to limited means of control for the intermediate host snail and absence of sanitary facilities in most endemic areas [29, 31, 32].”
BackgroundThe Drugs We Have and the Drugs We Need Against Major Helminth Infections
Keiser, J., & Utzinger, J. (2010) · Advances in Parasitology · doi:10.1016/s0065-308x(10)73008-6 · Cited by 288 · cited 1×
“Since the last surge of drug discovery for parasitic worm diseases in the 1970s, resulting in the marketing of praziquantel and ivermectin that, together, cure several of the major helminth infections [33], no new drugs for helminthiases have been approved.”
BackgroundSelf-citationGryseels, B. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.03.004 · Cited by 280
Lai, Y.-S., Biedermann, P., Ekpo, U. F., Garba, A., Mathieu, E., Midzi, N., Mwinzi, P., N'Goran, E. K., Raso, G., Assaré, R. K., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00066-3 · Cited by 278 · cited 8×
“Lai YS, Biedermann P, Ekpo UF, Garba A, Mathieu E, Midzi N, Mwinzi P, N’Goran EK, Raso G, Assaré RK, et al. Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis.”
BackgroundInfluentialSelf-citationNeglected tropical diseases: diagnosis, clinical management, treatment and control
Utzinger, J., Becker, S. L., Knopp, S., Blum, J., Neumayr, A. L., Keiser, J., & Hatz, C. F. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13727 · Cited by 265 · cited 1×
“The disease is one of today’s foremost neglected tropical diseases (NTDs) and a disease of poverty [3, 4].”
BackgroundSelf-citationThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Woodrow, C. J., & White, N. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw037 · Cited by 251 · cited 1×
“Judging from the veterinary field, development of drug resistance in helminthiasis can be swift [35] and the situation with respect to malaria is a constant reminder of this risk [36].”
BackgroundAwadzi, K., Opoku, N. O., Attah, S. K., Lazdins-Helds, J., & Kuesel, A. C. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002953 · Cited by 233
Artemisinins for schistosomiasis and beyond.
Utzinger, J., Xiao, S.-H., Tanner, M., & Keiser, J. (2007) · PubMed · Cited by 232
Self-citationUtzinger, J., N’Goran, E. K., Caffrey, C. R., & Keiser, J. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2010.08.020 · Cited by 227
Self-citationAbdulla, M.-H., Ruelas, D. S., Wolff, B., Snedecor, J., Lim, K.-C., Xu, F., Renslo, A. R., Williams, J., McKerrow, J. H., & Caffrey, C. R. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000478 · Cited by 224 · cited 1×
“[85] tested a large number of natural and synthetic compounds against S.”
BackgroundSokolow, S. H., Wood, C. L., Jones, I. J., Swartz, S. J., Lopez, M., Hsieh, M. H., Lafferty, K. D., Kuris, A. M., Rickards, C., & De Leo, G. A. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004794 · Cited by 223 · cited 1×
“However, control – let alone elimination – of schistosomiasis has proven difficult because of rapid re-infection due to limited means of control for the intermediate host snail and absence of sanitary facilities in most endemic areas [29, 31, 32].”
BackgroundOral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial
Utzinger, J., N'Goran, E. K., N'Dri, A., Lengeler, C., Shuhua, X., & Tanner, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02114-0 · Cited by 218 · cited 1×
“Subsequent clinical trials confirmed the protective efficacy for artemether [96, 97] and artesunate [98] and encouraged many articles discussing the advantage (and potential disadvantages) of including the artemisinins along with praziquantel in areas endemic for schistosomiasis and co-endemic for malaria [88, 90].”
BackgroundSelf-citationMefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice
Keiser, J., Chollet, J., Xiao, S.-H., Mei, J.-Y., Jiao, P.-Y., Utzinger, J., & Tanner, M. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000350 · Cited by 201
Self-citationRepurposing drugs for the treatment and control of helminth infections
Panic, G., Duthaler, U., Speich, B., & Keiser, J. (2014) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.07.002 · Cited by 199 · cited 1×
“Indeed, the idea of repositioning drugs is an inexpensive, yet effective source of new lead compounds for use against schistosomiasis, which has already resulted in several promising leads [50].”
BackgroundSelf-citationIn Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome Species
Xiao, S.-H., Keiser, J., Chollet, J., Utzinger, J., Dong, Y., Endriss, Y., Vennerstrom, J. L., & Tanner, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01537-06 · Cited by 184
Self-citationLo, N. C., Addiss, D. G., Hotez, P. J., King, C. H., Stothard, J. R., Evans, D. S., Colley, D. G., Lin, W., Coulibaly, J. T., Bustinduy, A. L., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30535-7 · Cited by 167 · cited 1×
“It has been used in preventive chemotherapy programmes in many endemic countries, in some continuously since more than 15 years [25, 110, 111].”
MethodSelf-citationThe position of mefloquine as a 21st century malaria chemoprophylaxis
Schlagenhauf, P., Adamcova, M., Regep, L., Schaerer, M. T., & Rhein, H.-G. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-357 · Cited by 164 · cited 1×
“[63] were the first to report an antischistosomal effect by mefloquine, an effective antimalarial agent that was introduced as a successor to chloroquine [64].”
BackgroundIn vitroandin vivotrematode models for chemotherapeutic studies
Keiser, J. (2009) · Parasitology · doi:10.1017/s0031182009991739 · Cited by 155 · cited 1×
“Phenotypic screens play an important role in antischistosomal drug discovery [37] and many products of potential value have been”
BackgroundSelf-citationArtemisinins and synthetic trioxolanes in the treatment of helminth infections
Keiser, J., & Utzinger, J. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f19ec4 · Cited by 152
Self-citationDrugs for treating urinary schistosomiasis
Kramer, C. V., Zhang, F., Sinclair, D., & Olliaro, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000053.pub3 · Cited by 147
Keiser, J., N’Guessan, N. A., Adoubryn, K. D., Silué, K. D., Vounatsou, P., Hatz, C., Utzinger, J., & N'Goran, E. K. (2010) · Clinical Infectious Diseases · doi:10.1086/651682 · Cited by 145 · cited 4×
“Mefloquine Not done Not done 21 74 [104]”
BackgroundInfluentialSelf-citationIn vitro and in vivo studies of the effect of artemether on Schistosoma mansoni
Xiao, S. H., & Catto, B. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1557 · Cited by 142 · cited 1×
“, artemether and artesunate) [52, 53] and synthetic derivatives”
BackgroundSchistosomiasis vaccines: where do we stand?
Tebeje, B. M., Harvie, M., You, H., Loukas, A. C., & McManus, D. P. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1799-4 · Cited by 142 · cited 1×
“This aspiration rests, however, on fragile grounds as inadequate funding has held back vaccine development and even if some good advances have been made [117], we are still years from potential field application of a schistosomiasis vaccine.”
BackgroundRecent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum
O’Brien, C., Henrich, P. P., Passi, N. N., & Fidock, D. A. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834cd3ed · Cited by 134 · cited 1×
“The risk for drug resistance due to widespread use of monotherapy with artemether or artesunate, however, must be taken seriously as the emergence of malaria parasites resistant to the artemisinins have shown [99, 100].”
BackgroundAntischistosomal activity of artemisinin derivatives in vivo and in patients
Saeed, M. E. M., Krishna, S., Greten, H. J., Kremsner, P. G., & Efferth, T. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.017 · Cited by 115
Villar, L., Burguillo, F. J., López‐Abán, J., & Muro, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045867 · Cited by 113 · cited 1×
“Subsequent clinical trials confirmed the protective efficacy for artemether [96, 97] and artesunate [98] and encouraged many articles discussing the advantage (and potential disadvantages) of including the artemisinins along with praziquantel in areas endemic for schistosomiasis and co-endemic for malaria [88, 90].”
BackgroundTrick or Treat: The Role of Vaccines in Integrated Schistosomiasis Control
Bergquist, R. N., Utzinger, J., & McManus, D. P. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000244 · Cited by 109
Self-citationN’GORAN, E. K., Utzinger, J., GNAKA, H. N., YAPI, A., N’Guessan, N. A., Silué, K. D., Lengeler, C., Chollet, J., SHUHUA, X., & Tanner, M. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.24 · Cited by 104 · cited 1×
“Subsequent clinical trials confirmed the protective efficacy for artemether [96, 97] and artesunate [98] and encouraged many articles discussing the advantage (and potential disadvantages) of including the artemisinins along with praziquantel in areas endemic for schistosomiasis and co-endemic for malaria [88, 90].”
BackgroundSelf-citationOlveda, R. M., Acosta, L. P., Tallo, V. L., Baltazar, P. I., Lesiguez, J. L. S., Estanislao, G. G., Ayaso, E. B., Monterde, D. B. S., Ida, A., Watson, N. L., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00345-x · Cited by 103 · cited 1×
“However, it is not until recently that preschool-aged children and pregnant women were included into the recommended target population for preventive chemotherapy [112, 113].”
BackgroundImportant Helminth Infections in Southeast Asia
Utzinger, J., Bergquist, R. N., Olveda, R. M., & Zhou, X. (2010) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(10)72001-7 · Cited by 103 · cited 1×
“japonicum remains endemic in seven provinces of the People’s Republic of China, The Philippines and three small Indonesian foci [12].”
BackgroundSelf-citationBorrmann, S., Szlezák, N., Faucher, J., Matsiegui, P., Neubauer, R., Binder, R. K., Lell, B., & Kremsner, P. G. (2001) · The Journal of Infectious Diseases · doi:10.1086/324004 · Cited by 102 · cited 1×
“Subsequent clinical trials confirmed the protective efficacy for artemether [96, 97] and artesunate [98] and encouraged many articles discussing the advantage (and potential disadvantages) of including the artemisinins along with praziquantel in areas endemic for schistosomiasis and co-endemic for malaria [88, 90].”
BackgroundNatural Products as Leads in Schistosome Drug Discovery
Neves, B. J., Andrade, C. H., & Cravo, P. (2015) · Molecules · doi:10.3390/molecules20021872 · Cited by 95 · cited 1×
“However, rather than discussing the many different schistosomicidal agents discovered in plant extracts here, we refer to recent reviews of the field by de Moraes [42] and Neves and colleagues [43].”
ResultAntimalarials in the Treatment of Schistosomiasis
Keiser, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212801327293 · Cited by 93 · cited 2×
“While the antimalarials are the most well-known group of drugs shown to have a strong action against schistosomes in addition to what they are intended for [49] several other pharmaceutical groups also contain compounds with such effect, notably drugs used for cancer therapy [51].”
BackgroundSelf-citationNatural Products with Antischistosomal Activity
de Moraes, J. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.23 · Cited by 93 · cited 2×
“However, rather than discussing the many different schistosomicidal agents discovered in plant extracts here, we refer to recent reviews of the field by de Moraes [42] and Neves and colleagues [43].”
ResultDiagnosis and treatment of schistosomiasis in children in the era of intensified control
Knopp, S., Becker, S. L., Ingram, K., Keiser, J., & Utzinger, J. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.844066 · Cited by 92 · cited 1×
“Antimony potassium tartrate, a potentially poisonous metalloid without distinctive effect, but known as an emetic and medicine against various ailments since ancient times marked the end of non-specific schistosomiasis chemotherapy [27, 28].”
BackgroundSelf-citationUtzinger, J., Chollet, J., Tu, Z., et al. (2002) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(02)90110-0 · Cited by 85 · cited 2×
“Artesunate 150 or 300 mg/kg/day for 7 days 34–49% 67–77% [53]”
BackgroundSelf-citationUtzinger, J., Shuhua, X., Keiser, J., Minggan, C., Jiang, Z., & Tanner, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371581 · Cited by 79
Self-citationSchistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice
Nassauw, L. V., Toovey, S., den bosch, J. V. O., Timmermans, J., & Vercruysse, J. (2008) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2008.06.006 · Cited by 73 · cited 1×
“[63] were the first to report an antischistosomal effect by mefloquine, an effective antimalarial agent that was introduced as a successor to chloroquine [64].”
BackgroundActivity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
Panić, G., Vargas, M., Scandale, I., & Keiser, J. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003962 · Cited by 71
Self-citationInteractions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro
Keiser, J., Manneck, T., & Vargas, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr178 · Cited by 69 · cited 2×
“Moreover, synergistic effects were observed when mefloquine and praziquantel were combined in the animal model [70].”
BackgroundSelf-citationSearch for antifungal, molluscicidal and larvicidal compounds from African medicinal plants
Marston, A., Maillard, M. P., & Hostettmann, K. (1993) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(93)90018-z · Cited by 67 · cited 1×
“It should, however, be noted that not only hits active against schistosomes but also against the snail intermediate host (plant molluscicides) and sometimes against other parasites were discovered [40].”
BackgroundPredictive risk mapping of schistosomiasis in Brazil using Bayesian geostatistical models
Scholte, R. G. C., Gosoniu, L., Malone, J. B., Chammartin, F., Utzinger, J., & Vounatsou, P. (2013) · Acta Tropica · doi:10.1016/j.actatropica.2013.12.007 · Cited by 65 · cited 3×
“mansoni additionally occurs in Latin America, most importantly in Brazil [11], while S.”
BackgroundInfluentialSelf-citationResearch and Development of Antischistosomal Drugs in the People's Republic of China
Xiao, S.-H., Keiser, J., Chen, M., Tanner, M., & Utzinger, J. (2010) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(10)73009-8 · Cited by 64
Self-citationTambo, E., Khater, E. I. M., Chen, J., Bergquist, R. N., & Zhou, X. (2015) · Infectious Diseases of Poverty · doi:10.1186/s40249-015-0091-8 · Cited by 63 · cited 1×
“Briefly, leaf extracts from the plant Artemisia annua recommended in Chinese traditional medicine against malaria (and other ailments), constituted the starting point for the development of the artemisinin-based combination therapy (ACT) currently in use against this infection [92, 93].”
BackgroundSelf-citationKeiser, J., Silué, K. D., Adiossan, L. G., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002975 · Cited by 60 · cited 2×
“Mefloquine-artesunate-praziquantel Not done Not done 29 96 [105]”
BackgroundSelf-citationCowan, N., Yaremenko, I. A., Борисович, К. И., Terent'ev, A. O., & Keiser, J. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.02.010 · Cited by 55 · cited 1×
“Bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, bridged 1,2,4-trioxolanes, silyl peroxides and hydroxylamines were also studied with the highest antischistosomal activity (in particular in vitro) observed for trioxolanes and tricyclic monoperoxides [62].”
BackgroundSelf-citationBustinduy, A. L., Friedman, J. F., Kjetland, E. F., Ezeamama, A. E., Kabatereine, N. B., Stothard, J. R., & King, C. H. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004946 · Cited by 55 · cited 2×
“However, it is not until recently that preschool-aged children and pregnant women were included into the recommended target population for preventive chemotherapy [112, 113].”
BackgroundFixed dose combination of arterolane and piperaquine: A newer prospect in antimalarial therapy
Patil, C., Baig, M., Doifode, S., & Katare, S. (2014) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.139270 · Cited by 46 · cited 5×
“Mossallam SF, Amer EI, El-Faham MH. Efficacy of Synriam, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni.”
BackgroundInfluentialTarget-Based Molecular Modeling Strategies for Schistosomiasis Drug Discovery
Ferreira, L. L. G., Oliva, G., & Andricopulo, A. D. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.21 · Cited by 43 · cited 1×
“Moreover, it is conceivable that drug discovery programmes using molecular modelling strategies will increasingly contribute to antischistosomal drug discovery [47, 48].”
BackgroundEl‐Moslemany, R. M., Eissa, M. M., Ramadan, A. A., El-Khordagui, L. K., & El‐Azzouni, M. Z. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.03.038 · Cited by 39
Barakat, R., El-Ela, N. E. A., Sharaf, S., Sagheer, O. E., Selim, S. M., Tallima, H., Bruins, M. J., Hadley, K. B., & Ridi, R. E. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0675 · Cited by 38 · cited 2×
“Praziquantel and ARA combined elicited 83% and 78% CRs in children with light and heavy infection, respectively [109].”
BackgroundActivities ofN,N′-Diarylurea MMV665852 Analogs against Schistosoma mansoni
Cowan, N., Dätwyler, P., Ernst, B., Wang, C., Vennerstrom, J. L., Spangenberg, T., & Keiser, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04463-14 · Cited by 32 · cited 1×
“The authors concluded that there is a need to synthesise compounds with improved solubility and pharmacokinetic properties [72].”
BackgroundSelf-citationACTs for schistosomiasis: do they act?
Utzinger, J., Tanner, M., & Keiser, J. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70169-9 · Cited by 31
Self-citationRe-Positioning Protein-Kinase Inhibitors Against Schistosomiasis
Gelmedin, V., Dissous, C., & Grevelding, C. G. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.31 · Cited by 30 · cited 1×
“In schistosomes, conserved protein kinases possess pivotal roles contributing not only to reproduction processes, but also to the pathology of schistosomiasis [79].”
BackgroundSelim, S. M., Sagheer, O. E., Amir, A. E., Barakat, R., Hadley, K. B., Bruins, M. J., & Ridi, R. E. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0328 · Cited by 30 · cited 1×
“mansoni infection given a good performance in a proof-of-concept study in children with light infections [108].”
BackgroundArtemisinin Combination Therapies and Malaria Parasite Drug Resistance: The Game Is Afoot
Taylor, S. M., & Juliano, J. J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu142 · Cited by 30 · cited 1×
“The risk for drug resistance due to widespread use of monotherapy with artemether or artesunate, however, must be taken seriously as the emergence of malaria parasites resistant to the artemisinins have shown [99, 100].”
BackgroundSchistosome genomes: a wealth of information
Webster, J. P., Oliviera, G., Rollinson, D., & Gower, C. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2009.12.006 · Cited by 30 · cited 1×
“Moreover, it is conceivable that drug discovery programmes using molecular modelling strategies will increasingly contribute to antischistosomal drug discovery [47, 48].”
BackgroundGuidi, A., Lalli, C., Perlas, E., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004928 · Cited by 29 · cited 3×
“Perhexiline maleate 23, 70 and 400 mg/kg single dose Not given Not given [83]”
BackgroundInfluentialElmorshedy, H., Tanner, M., Bergquist, R. N., Sharaf, S., & Barakat, R. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.02.015 · Cited by 28 · cited 1×
“There is no single prophylactic drug that can reliably protect against schistosome infection, but the combination of praziquantel and artemether comes close [101].”
BackgroundSelf-citationChemistry and Pharmacology of Neglected Helminthic Diseases
Mullner, A., Helfer, A., Kotlyar, D., Oswald, J., & Efferth, T. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794480096 · Cited by 23 · cited 1×
“While the antimalarials are the most well-known group of drugs shown to have a strong action against schistosomes in addition to what they are intended for [49] several other pharmaceutical groups also contain compounds with such effect, notably drugs used for cancer therapy [51].”
BackgroundHong, Q.-B., Yang, K., Huang, Y.-X., Sun, L., Yang, G., Gao, Y., Gao, Y., Zhang, L.-H., Zhou, M., Steinmann, P., et al. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2010.11.006 · Cited by 23
Genchi, C., Poglayen, G., Kramer, L. H., Venco, L., & Agostini, A. (2001) · PubMed · Cited by 22
Therapeutic effect of mefloquine on Schistosoma mansoni in experimental infection in mice
Abou-Shady, O. M., Mohammed, S. S., Attia, S. S., Yousof, H.-A. S. A., & Helmy, D. O. (2014) · Journal of Parasitic Diseases · doi:10.1007/s12639-014-0489-4 · Cited by 13 · cited 1×
“In addition, mefloquine had a strong effect on tissue egg load and number of liver granulomas [67].”
BackgroundLeonidova, A., Vargas, M., Huwyler, J., & Keiser, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02394-15 · Cited by 8
Self-citation
Cited by
The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand
Chan, J. D., Cupit, P. M., Gunaratne, G. S., McCorvy, J. D., Yang, Y., Stoltz, K., Webb, T. R., Dosa, P. I., Roth, B. L., Abagyan, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02084-0 · Cited by 69
Beutler, M., Harnischfeger, J., Weber, M. H. W., Hahnel, S. R., Quack, T., Blohm, A., Ueberall, M. E., Timm, T., Lochnit, G., Rennar, G. A., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115179 · Cited by 10
Metadata
- Authors
- Bergquist, R., Utzinger, J., & Keiser, J.
- Venue
- Infectious Diseases of Poverty
- Published
- 2017-03-28
- Volume
- 6
- Issue
- 1
- Pages
- 74-74
- ISSN
- 2049-9957 (ISSN-L)
- OpenAlex
- W2599189039
- Cited by
- 195
- References
- 86
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.